Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast cream in chronic plaque psoriasis
jRCT2031250298Active, not recruiting
- Sponsor
- Sato Pharmaceutical
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in plaque psoriasis comparing Roflumilast cream (two doses) with Vehicle then roflumilast cream (2 arms). Primary endpoint: Investigator Global Assessment (IGA) success rate at Week 8. Started Aug 2025; status: active, not recruiting.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2031250298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250298.